Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) PEG Ratio: N/A (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920566 Sichuan Zitonggong Pharmaceutical Co Ltd BJSE:920566
83 GF Score
Price ¥9.79
GF Value ¥10.55
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Sichuan Zitonggong Pharmaceutical Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Sichuan Zitonggong Pharmaceutical Co's PE Ratio without NRI is 16.88. Sichuan Zitonggong Pharmaceutical Co's 5-Year EBITDA growth rate is -3.00%. Therefore, Sichuan Zitonggong Pharmaceutical Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Sichuan Zitonggong Pharmaceutical Co's PEG Ratio or its related term are showing as below:


During the past 13 years, Sichuan Zitonggong Pharmaceutical Co's highest PEG Ratio was 17.17. The lowest was 0.19. And the median was 0.72.


BJSE:920566's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.74
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Sichuan Zitonggong Pharmaceutical Co  (BJSE:920566) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Sichuan Zitonggong Pharmaceutical Co PEG Ratio Related Terms


Sichuan Zitonggong Pharmaceutical Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for Sichuan Zitonggong Pharmaceutical Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Zitonggong Pharmaceutical Co PEG Ratio Chart

Sichuan Zitonggong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.54 1.06 12.23 0.00

Sichuan Zitonggong Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BJSE:920566 vs ZTS: PEG Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Zitonggong Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Zitonggong Pharmaceutical Co PEG Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Zitonggong Pharmaceutical Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Sichuan Zitonggong Pharmaceutical Co's PEG Ratio falls into.


BJSE:920566
83GF Score
Sichuan Zitonggong Pharmaceutical Co Ltd BJSE:920566
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sichuan Zitonggong Pharmaceutical Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Sichuan Zitonggong Pharmaceutical Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=16.879310344828/-3.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) Overvalued in 2026?

Based on GuruFocus' analysis, Sichuan Zitonggong Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥9.79 is trading 7.2% below its estimated GF Value™ of ¥10.55. GuruFocus considers Sichuan Zitonggong Pharmaceutical Co to be Fairly Valued.

Key valuation signals for BJSE:920566:

  • PEG Ratio: N/A
  • GF Value™: ¥10.55 vs. price of ¥9.79 (7.2% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the BJSE:920566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sichuan Zitonggong Pharmaceutical Co Business Description

Address No. 456, Anji Street, Economic and Technological Development Zone, Sichuan Province, Neijiang, CHN, 641000
Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties, such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.
83GF Score

Get the complete analysis for BJSE:920566

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.79
Price
¥10.55
GF Value